83 related articles for article (PubMed ID: 19837091)
1. Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors.
Kvistborg P; Bechmann CM; Pedersen AW; Toh HC; Claesson MH; Zocca MB
Vaccine; 2009 Dec; 28(2):542-7. PubMed ID: 19837091
[TBL] [Abstract][Full Text] [Related]
2. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
3. Autologous dendritic cell vaccines for non-small-cell lung cancer.
Hirschowitz EA; Foody T; Kryscio R; Dickson L; Sturgill J; Yannelli J
J Clin Oncol; 2004 Jul; 22(14):2808-15. PubMed ID: 15254048
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules.
Morse MA; Clay TM; Hobeika AC; Osada T; Khan S; Chui S; Niedzwiecki D; Panicali D; Schlom J; Lyerly HK
Clin Cancer Res; 2005 Apr; 11(8):3017-24. PubMed ID: 15837756
[TBL] [Abstract][Full Text] [Related]
5. Fast generation of dendritic cells.
Kvistborg P; Boegh M; Pedersen AW; Claesson MH; Zocca MB
Cell Immunol; 2009; 260(1):56-62. PubMed ID: 19818956
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional characterization of mature dendritic cells from pediatric cancer patients.
Jacobs JF; Hoogerbrugge PM; de Rakt MW; Aarntzen EH; Figdor CG; Adema GJ; de Vries IJ
Pediatr Blood Cancer; 2007 Dec; 49(7):924-7. PubMed ID: 17486645
[TBL] [Abstract][Full Text] [Related]
7. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
Shilyansky J; Jacobs P; Doffek K; Sugg SL
J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency.
Gervais A; Levêque J; Bouet-Toussaint F; Burtin F; Lesimple T; Sulpice L; Patard JJ; Genetet N; Catros-Quemener V
Breast Cancer Res; 2005; 7(3):R326-35. PubMed ID: 15987427
[TBL] [Abstract][Full Text] [Related]
9. Impaired maturation of monocyte-derived dendritic cells from birch allergic individuals in association with birch-specific immune responses.
Casas R; Skarsvik S; Lindström A; Zetterström O; Duchén K
Scand J Immunol; 2007 Nov; 66(5):591-8. PubMed ID: 17868259
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.
Delcayre A; Shu H; Le Pecq JB
Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959
[TBL] [Abstract][Full Text] [Related]
11. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
12. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
You J; Wang CL; Hao XS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
[TBL] [Abstract][Full Text] [Related]
16. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.
Waeckerle-Men Y; Scandella E; Uetz-Von Allmen E; Ludewig B; Gillessen S; Merkle HP; Gander B; Groettrup M
J Immunol Methods; 2004 Apr; 287(1-2):109-24. PubMed ID: 15099760
[TBL] [Abstract][Full Text] [Related]
17. Biological characteristics of dendritic cells derived from peripheral blood of patients with epithelial ovarian cancer.
Lan CY; Liu JH; Xia JC; Zheng LM
Ai Zheng; 2009 Feb; 28(2):132-7. PubMed ID: 19550123
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.
Bohnenkamp HR; Burchell JM; Taylor-Papadimitriou J; Noll T
J Immunol Methods; 2004 Nov; 294(1-2):67-80. PubMed ID: 15604017
[TBL] [Abstract][Full Text] [Related]
19. The large scale generation of dendritic cells for the immunization of patients with non-small cell lung cancer (NSCLC).
Yannelli JR; Sturgill J; Foody T; Hirschowitz E
Lung Cancer; 2005 Mar; 47(3):337-50. PubMed ID: 15713517
[TBL] [Abstract][Full Text] [Related]
20. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
Chang GC; Lan HC; Juang SH; Wu YC; Lee HC; Hung YM; Yang HY; Whang-Peng J; Liu KJ
Cancer; 2005 Feb; 103(4):763-71. PubMed ID: 15637694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]